Dissolution properties of control released solid dispersion of carvedilol with HPMC and Eudragit RS

Journal of Pharmaceutical Investigation

Volumn 42, Issue 5, 2012, Pages 285-291

  Shim, Jung Bo ^a   Kim, Min Jeong ^a   Kim, Seul Ji ^a   Kang, Su Ji ^a   Lee, Ji Hye ^a   Kim, Hyeong Seok ^a   Lee, Dongwon ^a   Khang, Gilson ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Carvedilol; Eudragit RS; HPMC; Solid dispersion; Spray dry

Indexed keywords

CARVEDILOL; DICHLOROMETHANE; EUDRAGIT RS; HYDROXYPROPYLMETHYLCELLULOSE; METHANOL;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID DISPERSION; SPRAY DRYING; THERMAL ANALYSIS; THERMOGRAPHY; X RAY POWDER DIFFRACTION;

EID: 84876565197     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-012-0037-0     Document Type: Article

References (28)

1. Ahn YS, Lee HY, Hong KD, Jung SB, Cho SH, Rhee JM, Lee HB, Khang G (2004) Effect of types and mixing ratios of water-soluble polymers on in vitro release profile of solid dispersion for acyclovir. J Korean Pharm Sci 34(4): 289-297.
2. Cho WH, Lee YH, Oh MJ, Lee D, Khang G (2010) Solubility characterization and improved dissolution of pranlukast with the surfactant. Int J Tissue Reg 1: 37-45.
3. Chung TS, Tun CM, Pramoda KP, Wang R (2001) Novel hollow fiber membranes with defined unit-step morphological change. J Membr Sci 193(1): 123-128.
4. Dahlberg C, Fureby AM, Schuleit M, Furó I (2010) Polymer-drug interactions and wetting of solid dispersions. Eur J Pharm Sci 39: 125-133.
5. Dunn CJ, Lea AP, Wagstaff AJ (1997) Carvedilol: a reappraisal of its pharmacological β-blockers in left ventricular dysfunction and heart failure. Drugs 54: 161-169.
6. Henderson EJ, Hessel CM, Veinot JGC (2008) Synthesis and photoluminescent properties of size-controlled germanium nanocrystals from phenyl trichlorogermane-derived polymers. J Am Chem Soc 130: 3624-3632.
7. Itai S, Nemoto M, Kouchiwa S, Murayama H, Nagagi T (1985) Influence of wetting factors on the dissolution behavior of flufenamic acid. Chem Pharm Bull 33: 5464-5473.
8. Jeong JK, Khang G, Rhee JM, Shin HC, Lee HB (2000) Effect of molecular weight and mixture ratio of PVP on improving the bioavailability of ipriflavone. J Korean Pharm Sci 30(4): 235-239.
9. Jeong JK, Kim JH, Khang G, Rhee JM, Lee HB (2002) The preparation and characterization of solid dispersion of ipriflavone with PVP. J Korean Pharm Sci 32(3): 173-179.
10. Khang G, Lee JH, Lee JW, Cho JC, Lee HB (2000) Preparation and characterization of PLGA microspheres for the sustained release of AZT. Korea Polym J 8(2): 80-88.
11. Khang G, Jeong JK, Rhee JM, LEE JS, Lee HB (2001) Effect of hydrophillic polymers on solid dispersion of ipriflavone to improve bioavailability. Macromol Chem Symp 14(3): 123-132.
12. Kim BS, Youn JY, Kim JY, Kim MS, Khang G, Lee HB (2007) Application of HPMC (Hydroxypropyl Methycellulose) as drug delivery carrier system. Polym Sci Technol 18(6): 549-553.
13. Kim YK, Lim DK, Lee SK, Eom S, Lee EY, Kim SJ, Lee D, Khang G (2010) Characterization and enhanced dissolution rate of nateglinide solid dispersion by using polyvinylacetal diethylaminoacetate. Int J Tissue Reg 1: 101-107.
14. Lee HB, Khang G, Cho JC, Rhee JM, Lee JS (1999) Fentanyl-loaded PLGA microspheres for local anesthesia. Polym Prepr 40(1): 288-289.
15. Lee JH, Ku J, Park JS, Park JH, Ahn SI, Mo JH, Kim YT, Rhee JM, Lee HB, Khang G (2008) Improved dissolution and characterization of solid dispersed atorvastatin calcium. J Korean Pharm Sci 38(2): 111-117.
16. Loftsson T, Vogensen SB, Desbos C, Jansook P (2008) Carvedilol: solubilization and cyclodextrin complexation: a technical note. AAPS Pharm Sci Technol 9: 425-430.
17. Mizoe T, Ozeki T, Okada H (2007) Preparation of drug nanoparticle-containing microparticles using a 4-fluid nozzle spray drier for oral, pulmonary, and injection dosage forms. J Control Release 122: 10-15.
18. Oh MJ, Shim JB, Lee EY, Yoo H, Cho WH, Lim DK, Lee D, Khang G (2011) Molecular effect of PVP on the release property of carvedilol solid dispersion. J Pharm Investig 41(3): 179-184.
19. Park JS, Oh JM, Kim YT, Lee JH, Kim MJ, Mo JH, Kim MS, Lee HB, Khang G (2008a) Release behavior from sibutramine microspheres using spray-dryer. Polymer (Korea) 32(3): 193-198.
20. Park JS, Jeong K, Lee JH, Kim YT, Park JH, Ahn SI, Mo JH, Lee HB, Khang G (2008b) Characterization and controlled release of solid dispersed sibutramine. J Pharm Investig 38(2): 119-126.
21. Piera DM, Roberta C, Christine B, Roberto G, Etienne J, Admir M, Pascal O, Sante M (2007) Characterization and compaction behaviour of nimesulide crystal forms. Int J Pharm 342: 137-144.
22. Robert R, Ruffolo RR, Boyle DA, Brooks DP, Feuerstein GZ, Venuti RP, Lukas MA, Paste G (1992) Carvedilol: a novel cardiovascular drug with multiple actions. Cardiovasc Drug Rev 10: 127-157.
23. Ruilope LR (1994) Comparison of a new vasodilating β-blocker, carvedilol with atenolol in the treatment of mild to moderate essential hypertension. Am J Hypertens 7: 129.
24. Seo S, Choi HS, Lee DH, Khang G, Lee HB (2001) Characteristics of nifedipine loaded PLGA wafer. Polymer (Korea) 25: 884-892.
25. Seong H, An TK, Khang G, Choi SU, Lee CO, Lee HB (2003) BCNU-loaded poly(d, l-lactic-co-glycolic acid) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro. Int J Pharm 251: 1-12.
26. Tanwar YS, Chauhan CS, Sharma A (2007) Development and evaluation of carvedilol transdermal patches. Acta Pharm 57: 151-159.
27. Walking WD (1994) Povidone. In: Wade A, Weller PJ (eds) Handbook of pharmaceutical excipients. American Pharmaceutical Association/The Pharmaceutical Press, Washington DC/London, pp 392-399.
28. Youn JY, Ku J, Lee SY, Kim BS, Kim MS, Lee B, Khang G, Lee HB (2007) The effect of drug release from osmotic pellet related to the various ratio of Eudragit RL and RS. Polymer (Korea) 31(4): 329-334.